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One of the challenging observations in breast cancer epidemiology
is the remarkable international variability of the disease
(Lipworth, 1995), Caucasian women in the US and UK having
substantially higher incidence than Asian women in China and
Japan despite rising rates among the latter. This variability cannot
be accounted for by genetic factors because the incidence of breast
cancer among the descendants of migrants from low-risk to high-
risk countries eventually reaches the incidence prevailing in the
host country (Ziegler et al, 1993). Although models have been
proposed to accommodate the international variation in breast
cancer occurrence on the basis of known risk factors (Pike et al,
1983), it appears that a substantial portion of this variation
between countries cannot be accounted for by the established risk
factors for breast cancer (Hsieh et al, 1990). Furthermore, most
analytical epidemiological studies exploring the role of diet during
adult life in the aetiology of breast cancer have found, at most,
weak associations; the relative risks linking any particular nutrient
or dietary pattern to this disease have been too close to the null
value of 1 to explain the large interpopulation variation (Rogers
and Longnecker, 1988; Hunter et al, 1996). It appears, therefore,
that the studied conditions or events during a woman’s adult life
have not provided an adequate explanation of breast cancer occur-
rence patterns.
The idea that breast cancer originates during early life was
advanced by MacMahon and colleagues on the basis of findings
concerning the striking protective effect of an early first full-term
pregnancy (Cole and MacMahon, 1969). Others have made similar
suggestions on the basis of the association between adult body
height and breast cancer risk (deWaard, 1975; Adami et al, 1990),
an association which is evident in international correlations and
also has been found in a number of case–control (Valaoras et al,
1969; Hsieh et al, 1990) and cohort (Tretli, 1989; van den Brandt
et al, 1997) studies. In addition, the gradual increase of breast
cancer risk over several generations of migrants points to early
events and conditions that could also include transgeneration
components (Ziegler et al, 1993). This last view is compatible with
experimental evidence in laboratory animals in which prenatal
exposures have been shown to increase the risk of cancer in the
offspring of several species (Tomatis, 1989).
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Summary Characteristics probably associated with the fetal hormonal milieu have recently been shown to increase (birth size indicators,
prematurity, neonatal jaundice) or decrease (pregnancy toxaemia) breast cancer risk in the female offspring. However, it is unknown whether
differences in pregnancy hormone levels may contribute to the marked geographical variation in breast cancer incidence. We have compared,
in a highly standardized manner, pregnancy hormone levels in a population with high incidence and one with low incidence of breast cancer.
Three hundred and four pregnant Caucasian women in Boston and 334 pregnant Chinese women in Shanghai were enrolled from March
1994 to October 1995. Levels of oestradiol, oestriol, prolactin, progesterone, human growth hormone, albumin and sex hormone-binding
globulin were measured in maternal blood at weeks 16 and 27 of gestation and compared between the two study sites using non-parametric
Wilcoxon’s rank-sum test. Demographical, anthropometrical and pregnancy characteristics were ascertained through interview, and relevant
variables concerning delivery and the newborn were abstracted from medical records and paediatric charts. During the first visit, median
serum levels of all studied hormones were statistically significant, and in most instances substantially, higher among Chinese women, who
have a low incidence of breast cancer, compared with American women, who have a high incidence of breast cancer. An analogous pattern
was evident during the second visit, although the relative differences tended to be smaller. Further research is needed to identify lifestyle or
other exogenous determinants of pregnancy hormone levels, as well as possible mechanisms by which they may influence carcinogenic
processes in the breast and possibly other organs.
Keywords: epidemiology; pregnancy steroids; breast cancer
7
British Journal of Cancer (1999) 79(1), 7–12
© 1999 Cancer Research Campaign
Received  12 February
Revised  18 May 1998
Accepted  18 June 1998
Correspondence to: L Lipworth, (present address) Department of Preventive
Medicine, Vanderbilt University School of Medicine, A-1124 Medical Center
North, Nashville, TN 37232, USAA number of recent epidemiological studies have pointed out
that several characteristics of pregnancy and parturition are likely
to be associated with the risk for breast cancer in the offspring.
These characteristics include cerebral asymmetry that is believed
to be conditioned by endocrine factors during the perinatal period
(Sandson et al, 1992), birthweight which is likely to be affected by
growth factors and perhaps exogenous influences (Michels et al,
1996; Sanderson et al, 1996; Ekbom et al, 1997), neonatal jaundice
of unspecified aetiology (Ekbom et al, 1997) and, inversely, 
pregnancy toxaemia that is associated with profound but poorly
understood endocrine changes (Ekbom et al, 1997). Although the
dynamics of the intrauterine environment are clearly complex,
hormones are central to its definition and notably oestrogens are
necessary for the normal development of the breast. We have
hypothesized that one or several of these hormones influence,
already in utero, the risk of developing cancer during adult life. To
evaluate this hypothesis, we have compared, for the first time,
pregnancy hormone levels in samples from two populations with
widely different rates for cancer of the breast – US and China.
MATERIALS AND METHODS
Subjects
Study subjects were adult pregnant women recruited from mater-
nity clinics affiliated with two study centres, Beth Israel Hospital
in Boston, MA, USA, and Shanghai Medical University in China.
In Boston, women were urban residents, whereas in Shanghai they
were recruited from three urban clinics and one rural clinic. In
each centre, an authorized health professional met all pregnant
women coming for their first routine prenatal visit to the collabo-
rating maternity clinic, ascertained whether the woman was
eligible to participate, explained to her the objectives of the study
and the requirements for participation, and obtained informed
consent.
To be eligible for participation, a pregnant woman had to be less
than 40 years of age, had to have no more than one previous still-
born or liveborn child, had to be Caucasian in Boston and Chinese
in Shanghai, and had to be able to understand and speak the local
language. Women were excluded if they had taken any hormonal
medication during the index pregnancy, if they had a prior diag-
nosis of diabetes mellitus or thyroid disease, or if the fetus had a
known major anomaly.
Between March 1994 and October 1995, a total of 402 eligible
women were identified at Beth Israel Hospital in Boston. Of these,
77 (19.2%) refused to participate, 11 (2.7%) were subsequently
excluded because of early pregnancy termination, either sponta-
neous or induced (n = 9), or twin birth (n = 2), whereas ten (2.5%)
were lost to follow-up after the initial meeting; thus, 304 pregnant
women were eventually included from the Boston site. In
Shanghai, a total of 424 eligible women were identified between
April 1994 and May 1995. Of these, 15 (3.5%) refused to partici-
pate, ten (2.4%) were subsequently excluded because of induced
abortion (n = 2), twin birth (n =2), or implied gestation duration
<30 or >50 weeks (n = 6), whereas 58 (13.7%) provided no blood
samples and seven (1.7%) were lost to follow-up after the initial
meeting; thus, 334 pregnant women were eventually enrolled in
the study from the Shanghai site.
Hormone levels were measured in maternal blood. Maternal
oestrogen levels have been shown to increase and correlate well
with gestational age, so that two measurements during pregnancy
will characterize better the mammary gland exposure to oestro-
gens and other hormones during gestation. Therefore, the first
sampling was scheduled to take place around the 16th (completed)
week of gestation. The second measurement was done around the
27th (completed) week of gestation; by then, the pregnancy is well
advanced and the gestational age-dependent increase of oestradiol
(E2) appears to slow down, thus minimizing the consequences of
the unavoidable small variability in the timing of blood sampling.
In both study centres, gestational age was defined as the time
since the first day of the last menstrual period. Around the 16th
week visit, blood pressure and baseline demographic information
were abstracted from the medical records of consenting partici-
pants and blood was drawn. Around the 27th week visit, the autho-
rized health professional conducted a confidential interview with
the study participant and abstracted relevant data from her records;
again, blood was drawn. In addition, at each of the two visits,
women were asked to complete a self-administered food
frequency questionnaire pertaining to their dietary patterns during
the previous trimester of pregnancy. At delivery, the placenta was
weighed before discarding; additional information concerning the
delivery and the newborn was ascertained from medical records
and paediatric charts and recorded at the pregnancy’s term.
Blood collection
From every woman, at each visit, 10 ml of venous blood was
drawn and collected into centrally provided sterile tubes without
preservative. After centrifugation, the serum from each sampling
was separated and equally distributed into aliquots centrally
provided and labelled with a blood sample number which was
linked, through the questionnaire, to subject’s name, study visit
and time and date of blood draw. All tubes had uniform labelling
for both Boston and Shanghai samples and for both study visits.
For the Boston site and the urban hospitals in China, blood
samples were kept refrigerated at 4°C for up to 24 h until centrifu-
gation. For the rural hospital of the China site, blood samples were
drawn between 8 a.m. and 10 a.m. and kept refrigerated at 4°C
until they were transported in a cooler to a laboratory near
Shanghai Medical University and centrifuged, between 1 p.m. and
2 p.m. the same day. The aliquots were stored at –20°C for about
5–7 days in the laboratory before being transported to Shanghai
Medical University and stored at –80°C. The aliquots of blood
from all women were stored locally at –80°C until all samples
were collected. The aliquots from Shanghai were then packed in
dry ice and transported to Boston in person by a researcher; the
sample were stored at –80°C in Boston until being shipped by air,
together with the Boston samples, to Uppsala, Sweden, where all
biochemical analyses were undertaken by one of us (LW).
Specifically, the aliquots were packed in dry ice, adequate to
last for at least twice the estimated length of transport time. It is
unlikely that any thawing occurred before the transport of the
serum samples to Uppsala; in any case, steroid hormones are quite
stable even when samples are frozen at –20°C and are repeatedly
thawed and refrozen (Kley and Rick, 1984; Kley et al, 1985;
Sinnecker, 1989).
Laboratory analyses
Sera which were clearly haemolysed and several with illegible
labels were omitted from the laboratory analyses. An equal
number of samples from each study site were analysed, the exclu-
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assay series, every second sample was from Boston and Shanghai
respectively. Thus, the number of serum specimens included from
each site was 303 for the first sample collection and 297 for the
second.
Four pools of serum samples served as controls: Shanghai first
sample collection, Shanghai second collection, Boston first collec-
tion and Boston second collection. Specimens from each pool were
placed at regular intervals in the series, treated like test samples,
and measured a total of 24 times for each analyte (hormone). The
mean levels of these control specimens, as well as the mean (±s.d.)
imprecision for each of the seven analytes, were calculated.
Oestradiol-17b (E2) in 25 ml serum, diluted 1:20, was measured
with a time-resolved competitive solid-phase fluoroimmunoassay
(AutoDELFIA Estradiol kit; Wallac Oy, Turku, Finland), based on
competition between europium-labelled oestradiol and sample
oestradiol for polyclonal anti-oestradiol antibodies (derived from
rabbit). A second antibody, directed against rabbit IgG, is coated
onto the walls of microtitre plates, and binds the IgG–oestradiol
complex. The cross-reactivity for oestrone and oestriol at the 50%
inhibition level was 0.75% and 0.40% respectively. The results
were expressed in nmol l–1. The imprecision was 4.6±0.8%.
Unconjugated oestriol (E3) in 50 ml serum was measured with a
similar time-resolved competitive solid-phase fluoroimmunoassay
method (AutoDELFIA Unconjugated Estriol kit, Wallac Oy,
Turku, Finland). The cross-reactivity at 50% inhibition was for
oestriol-3-sulphate 37%, for oestriol-3-glucuronide 37% and for
oestradiol <0.1%. The results were expressed in nmol l–1. The
imprecision was 8.0±1.8%.
Prolactin (hPRL) in 25 ml of serum was measured with a 
time-resolved non-competitive solid-phase sandwich fluoro-
immunoassay in which two monoclonal antibodies (derived from
mice) are directed against two separate antigenic determinants on
the hPRL molecule (AutoDELFIA Prolactin kit; Wallac Oy,
Turku, Finland). The results were expressed in mg l–1. One mg = 
36 mU of the WHO 3rd International Standard (84/500) for
prolactin. The imprecision was 3.0±0.3%.
Progesterone in 25 ml serum, diluted 1:8, was measured with a
similar time-resolved competitive solid-phase fluoroimmunoassay
method (AutoDELFIA Progesterone kit; Wallac Oy, Turku,
Finland). The results were expressed in nmol l–1. The imprecison
was 1.67±0.9%.
Human growth hormone (hGH) in 25 ml serum was measured
with similar time-resolved non-competitive solid-phase sandwich
fluoroimmunoassay (AutoDELFIA hGH, Wallac OY, Turku,
Finland). The hGH assay was specific for the pituitary 22-kDa
isoforms of hGH. The results were expressed in mU l–1, using a
recombinant human pituitary GH (22 kDa) as a standard calibrated
against the WHO 1st International Reference Preparation (80/505)
for hGH. The imprecision was 2.9±0.2%.
Albumin in 3 ml serum was measured with an automated
analysis Hitachi System 717, using bromocresol green as a
reagent. The method was calibrated against an immunoassay for
human serum albumin. The results were expressed in g l–1. The
imprecision was 1.8±0.2%.
Sex hormone-binding globulin (SHBG) in 25 ml serum, diluted
1:100, was measured with similar time-resolved non-competitive
solid-phase sandwich fluoroimmunoassay (AutoDELFIA SHBG
kit, Wallac OY, Turku, Finland). The results were expressed in
nmol l–1, using as a reference a recombinant human SHBG prepa-
ration. The imprecision was 4.8±1.3%.
Statistical analyses
Non-parametric Wilcoxon’s rank-sum test was applied in
univariate comparisons of the hormone levels between the two
study sites (Armitage and Berry, 1987). Multivariate analysis was
based on modelling through multiple regression, using the loga-
rithm of the hormone levels as the dependent variables. The level
of statistical significance was set at P<0.05, two-sided.
RESULTS
Maternal, newborn and gestation characteristics are presented for
American and Chinese women in Table 1. The age range of
women at each study centre was 19–39 years. The mean age was
higher among American (31 years) than among Chinese (24 years)
women. Also, pregnant women in Boston were on average taller
and heavier than pregnant women in Shanghai. With respect to
newborn characteristics, those born to American women had
higher birthweight than those born to Chinese women. On
average, total duration of gestation was similar among the two
groups, as were completed weeks of gestation at the first blood
sampling stage; the second blood sample was, however, collected
on average 1 day earlier in gestation among Chinese than in
American women. With respect to parity status, 36.8% of
American women reported a previous full-term pregnancy,
compared with only 3% of Chinese women – an expected finding
given the restrictions on family size in China.
Table 2 shows concentrations of the measured hormonal vari-
ables and of albumin and SHBG in serum samples collected at
about 16 and 27 completed weeks of gestation among pregnant
women in Boston and Shanghai. For each of the variables, values
were generally within the expected range for pregnant women at
those particular stages of pregnancy. Median levels of all the
studied hormones were statistically significantly – and in most
instances substantially – higher among Chinese women during the
first visit (P<0.01). An analogous pattern was evident during the
second visit, although the relative differences tended to be smaller
and, for progesterone, the values were actually somewhat higher
among American women. The magnitudes of the differences
between Chinese and American women remained essentially
unchanged after adjusting for maternal age and parity in a regres-
sion analysis that used the log-transformed hormone level as the
dependent variable. There were no statistically significant differ-
ences among the four clinics in Shanghai (data not shown).
Minor differences by gender of the offspring were noted that
reached statistical significance at the 0.05 level with respect to:
progesterone levels among American women at both visits
(median levels for women with male or female fetus were 139 and
125 nmol l–1, respectively, at first visit, and 273 and 240 nmol l–1,
respectively, at second visit); oestradiol levels among Chinese
women at second visit (median levels for women with male or
female fetus were 42.8 and 46.2 nmol l–1 respectively).
DISCUSSION
This study was designed to address the question of whether
hormonal factors during pregnancy could explain a series of
associations reported from different populations between
perinatal characteristics and breast cancer risk. In the process, data
concerning hormone levels at two pregnancy stages for Caucasian
women in the US and for Chinese women in Shanghai were
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perinatal epidemiology.
Early life events and conditions, including the intrauterine period,
have recently received increasing attention in the context of several
adult-onset diseases, including cardiovascular diseases (Bakketeig
et al, 1991; Barker, 1995) and a number of malignancies (Kaye et al,
1991; Cnattingius et al, 1995; Tibblin et al, 1995; Akre et al, 1996;
Michels et al, 1996; Sanderson et al, 1996; Ekbom et al, 1996,
1997). Among adult-onset cancers, the data are stronger with
respect to breast cancer: the evidence comes from studies showing a
positive association of birth size indicators with both breast cancer
itself and high-risk mammograms (Ekbom et al, 1995, 1997;
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Table 1 Maternal, newborn and gestation characteristics among 304 pregnant women from Boston, USA, and 334 pregnant women from
Shanghai, China
na Mean ± s.d. Median Range P-valuesb
Maternal
Age (years) Boston 304 31.0 ± 3.1 31 19–39 0.0001
Shanghai 334 25.1 ± 3.8 24 19–39
Weight (kg) Boston 296 60.0 ± 9.8 59 39–113 0.0001
Shanghai 332 51.2 ± 6.0 50 35–75
Height (cm) Boston 298 164.3 ± 6.5 165 150–188 0.0001
Shanghai 334 160.1 ± 4.7 160 147–174
BMI (kg m–2) Boston 296 22.2 ± 3.2 21.5 16.8–36.0 0.0001
Shanghai 332 20.0 ± 2.1 19.8 14.3–28.6
Newborn
Birthweight (g) Boston 304 3501 ± 538 3515 1725–4970 0.004
Shanghai 334 3392 ± 463 3400 1800–4800c
Birth length (cm) Boston 304 50.3 ± 2.6 51 37–57 0.01
Shanghai 334 49.8 ± 2.7 50 30–56
Head circumference (cm) Boston 296 34.4 ± 1.8 34.5 24–38.5 0.84
Shanghai 320 34.5 ± 2.0 34 28–41d
Placenta weight (g) Boston 210 586.5 ± 154.1 580 280–1020e 0.009
Shanghai 302 610.4 ± 143.4 600 226–1000f
Gestation
Total duration (weeks) Boston 294 39.9 ± 1.9 40 31.7–48.3 0.60
Shanghai 326 39.8 ± 1.8 39.9 31.1–47.7
At sample 1 (weeks) Boston 278 16.8 ± 1.3 16.6 12.7–27.1 0.83
Shanghai 283 16.9 ± 1.6 16.7 11.7–24.7
At sample 2 (weeks) Boston 276 27.2 ± 1.9 27.6 21.7–37.1 0.002
Shanghai 275 27.0 ± 1.6 26.7 20.3–38.1
aThe differences reflect missing values. bWilcoxon rank-sum test P-values comparing US and Chinese women. cOne observation with birthweight =
998 g. dTwo observations with head circumference = 51 cm. eOne observation with placenta weight = 1620 g. fOne observation with placenta
weight = 1600 g.
Table 2 Serum levels of studied hormones at 16 and 27 completed weeks of gestation among pregnant women in Boston, USA, and in
Shanghai, Chinaa
Sample 1 Sample 2
Hormone n Mean ± s.d. Median Range n Mean ± s.d. Median Range
Oestradiol (E2) Boston 288 14.0 ± 6.4 12.6 3.1–43.3 286 39.1 ± 16.6 36.4 12.9–145.9
(nmol l–1) Shanghai 291 20.7 ± 9.7 18.3 5.1–67.7 283 48.2 ± 18.3 44.2 16.7–152.9
Oestriol (E3) Boston 288 3.9 ± 1.7 3.5 0.4–11.0 286 14.0 ± 4.4 13.5 5.8–30.5
(nmol l–1) Shanghai 291 6.3 ± 3.9 5.4 1.03–27.8 283 21.9 ± 9.5 20.4 7.6–107.0
Prolactin Boston 288 44.7 ± 24.5 40.2 5.5–210.5 286 91.3 ± 35.5 89.4 19.4–321.4
(mg l–1) Shanghai 291 63.1 ± 32.5 58.8 12.5–274.1 283 116.0 ± 37.5 113.3 41.8–266.9
Progesterone Boston 288 133.0 ± 31.8 131.0 57.3–255.0 286 263.3 ± 69.3 252.0 109.0–544.0
(nmol l–1) Shanghai 291 143.3 ± 35.9 139.0 67.6–305.0 283 247.8 ± 80.5 236.0 112.0–735.0
Growth hormone Boston 288 2.98 ± 3.84 1.43 0.02–22.94 286 0.90 ± 1.54 0.28 0.02–11.0
(mU l–1) Shanghai 291 3.69 ± 3.78 2.35 0.05–19.46 283 1.74 ± 2.55 0.80 0.05–25.4
Albumin Boston 288 40.2 ± 2.2 40.3 34.5–47.1 286 36.5 ± 2.0 36.6 30.9–42.8
(g l–1) Shanghai 291 43.2 ± 2.6 43.1 36.4–50.3 283 39.6 ± 2.2 39.3 34.4–46.3
SHBG Boston 288 362.4 ± 90.4 365.9 117.9–606.3 286 425.6 ± 111.2 420.2 137.9–774.5
(nmol l–1) Shanghai 291 429.4 ± 90.8 427.1 205.0–653.9 283 479.5 ± 122.3 465.8 186.1–977.6
aAll differences between sites at each visit were statistically significant (P<0.05).Michels et al, 1996; Sanderson et al, 1996), findings which suggest
that the excess risk for breast cancer is higher when a sister rather
than the mother is affected among first-degree relatives (Eby et al,
1994; Bernstein et al, 1995; Hunter et al, 1997), investigations
linking cerebral asymmetry to breast cancer risk (Sandson et al,
1992), and data indicating that pregnancy toxaemia is inversely and
neonatal jaundice is positively associated with breast cancer risk in
the offspring (Ekbom et al, 1997).
Of the steroid hormones measured in the present study, proges-
terone is entirely of indirect maternal origin, formed by the
placenta from maternal low density lipoprotein (LDL) cholesterol.
Oestradiol-17b is synthesized in the placenta by 50% from
maternal and by 50% from fetal androgen precursors. In contrast,
oestriol is formed by more than 90% by placental conversion 
of fetal 16a-hydroxydehydroepiandrosterone and its sulphate
(Falcone and Little, 1994). Oestradiol-17b and, especially, oestriol
levels were considerably higher in Chinese than in American
women at both sampling stages. This difference would still remain
after adjustment for different placental weight/bodyweight ratios,
and for a relative dehydration in the Chinese women as indicated
by their higher serum albumin values. The elevated oestrogen
levels in Chinese women may, thus, reflect an increased 
production by these women of androgens from the fetal adrenal
glands, including 16a-hydroxydehydroepiandrosterone and de-
hydroepiandrosterone. Little is known about the effects of these
steroids on breast development. However, an increased adrenal
androgen production may reflect differences in other factors, such
as growth factors, that could affect breast development (Murphy
and Branchaud, 1994).
Because oestrogens in the adult life, whether endogenous or
exogeneous (Peto, 1989; Toniolo et al, 1995), appear to be impor-
tant in breast carcinogenesis, it would be natural to speculate that
high levels of pregnancy oestrogens would be critical for the
intrauterine origin of this disease. The data presented here,
however, contradict strongly a straightforward positive association
between actual oestrogen levels during pregnancy and risk for
breast cancer – whether one focuses on oestradiol (E2) or the
abundantly produced oestriol (E3). In fact, in the present study, all
measured pregnancy hormones as well as SHBG and albumin
were substantially higher among Chinese women than among
Caucasian American women, with the possible exception of pro-
gesterone during the late stage sampling. This ecological contrast
contradicts the a priori hypothesis that invokes levels of pregnancy
oestrogens as an important factor in the intrauterine processes that
modulate breast cancer risk. Oestrogens and other pregnancy
hormones, however, could influence breast cancer risk through
more indirect or complex processes.
There are various plausible mechanisms that could accommo-
date an oestrogen-mediated effect on breast cancer risk as well as
higher levels of pregnancy oestrogens in the low-risk population.
First, it is possible that higher oestrogen levels in the intrauterine
period down-regulate the expression of oestrogen receptors in
breast tissue throughout life through some form of imprinting.
There is little information about concentrations of oestrogen
receptors in normal breast tissue compared with breast cancer, but
what information exists does indicate that concentrations are
substantially higher in Caucasian women than in Japanese women,
who share with Chinese a low risk for breast cancer (Punnonen et
al, 1984; Pegoraro et al, 1986). Second, higher levels of pregnancy
oestrogens in conjunction with high levels of other mammotrophic
hormones could advance differentiation of mammary cells,
making them less susceptible to carcinogenesis, in the context of 
a mechanism postulated by Russo and Russo (1996). Last, it is
possible that the higher albumin and SHBG levels among Chinese
could imply different bioavailability of oestrogens in Chinese
compared with American women, although lack of data on other
steroids, particularly testosterone, and perhaps other relevant vari-
ables in the intrauterine hormonal environment hinders estimation
of free oestradiol. As a corollary in adult life, breast cancer
patients have (even before diagnosis) consistently lower levels of
SHBG (Lipworth et al, 1996).
The data of the present study confirm that birthweight is lower
among Chinese than among Caucasian women, even though none
of the measured growth factors could explain the difference. It has
been suggested that the intercorrelated size of the stem cell pool
(Albanes and Winick, 1988; Trichopoulos and Lipman, 1992;
Trichopoulos and Lipworth, 1995) or number of replications
(Albanes and Winick, 1988; Preston-Martin et al, 1990) could be a
background risk factor on which the effects of later-acting causes
of breast cancer are superimposed.
The evidence linking perinatal factors to breast cancer risk is
strong (Adami et al, 1995; Michels et al, 1996; Ekbom et al, 1997).
The present study demonstrates striking differences in the
intrauterine endocrine environment between American and Chinese
women. This large amount of data concerning pregnancy hormones
and their correlates should pave the way for a better understanding
of the physiological processes during gestation and the way these
could affect perinatal and adult life events and conditions. Although
we have discussed our findings in relation to breast cancer, they
clearly could be relevant to other malignancies, such as cancer of the
testis and prostate (Akre et al, 1996; Ekbom et al, 1996), the inci-
dence of which differs between the two studied populations.
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